AbbVie to Host First-Quarter 2018 Earnings Conference Call
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Abbvie (ABBV) CL 'Buy' Rating Reiterated at Goldman Sachs Following Management Meetings; 'Sell-Off Misaligned with Fundamentals'
April 6, 2018 9:00 AM EDTGoldman Sachs maintained its price target on Abbvie (NYSE: ABBV) at $135.00 while maintaining a Conviction Buy rating, following meetings with management.
Analyst Jami Rubin reiterates the outlook and price target on the shares, despite the recent sell-off in shares (down 19.51% over the... More
